Keywords: pathogenesis, look, tobi, early, cf, patients, corp

PathoGenesis to look at TOBI in early CF patients

Article | 01 June 2000

Print This

PathoGenesis Corp has begun enrollment into a Phase IV clinicaltrial of TOBI (tobramycin solution for inhalation) in cystic fibrosis patients ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in